Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia

被引:198
作者
Fervaha, G. [1 ,2 ]
Foussias, G. [1 ,2 ,3 ]
Agid, O. [1 ,2 ,3 ]
Remington, G. [1 ,2 ,3 ]
机构
[1] Ctr Addict & Mental Hlth, Schizophrenia Div, Toronto, ON M5T 1R8, Canada
[2] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[3] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
关键词
schizophrenia; functional outcome; negative symptoms; neurocognition; amotivation; avolition-apathy; QUALITY-OF-LIFE; CLINICAL ANTIPSYCHOTIC TRIALS; CONSENSUS COGNITIVE BATTERY; EFFECTIVENESS CATIE PROJECT; RANDOMIZED CONTROLLED-TRIAL; NEGATIVE SYMPTOMS; INTRINSIC MOTIVATION; RATING-SCALE; FOLLOW-UP; APATHY;
D O I
10.1111/acps.12289
中图分类号
R749 [精神病学];
学科分类号
100204 [神经病学];
摘要
ObjectiveFunctional impairment is characteristic of most individuals with schizophrenia; however, the key variables that undermine community functioning are not well understood. This study evaluated the association between selected clinical variables and one-year longitudinal functional outcomes in patients with schizophrenia. MethodThe sample included 754 patients with schizophrenia who completed both baseline and one-year follow-up visits in the CATIE study. Patients were evaluated with a comprehensive battery of assessments capturing symptom severity and cognitive performance among other variables. The primary outcome variable was functional status one-year postbaseline measured using the Heinrichs-Carpenter Quality of Life Scale. ResultsFactor analysis of negative symptom items revealed two factors reflecting diminished expression and amotivation. Multivariate regression modeling revealed several significant independent predictors of longitudinal functioning scores. The strongest predictors were baseline amotivation and neurocognition. Both amotivation and neurocognition also had independent predictive value for each of the domains of functioning assessed (e.g., vocational). ConclusionBoth motivational and neurocognitive deficits independently contribute to longitudinal functional outcomes assessed 1year later among patients with schizophrenia. Both of these domains of psychopathology impede functional recovery; hence, it follows that treatments ameliorating each of these symptoms should promote community functioning among individuals with schizophrenia.
引用
收藏
页码:290 / 299
页数:10
相关论文
共 63 条
[1]
A DEPRESSION RATING-SCALE FOR SCHIZOPHRENICS [J].
ADDINGTON, D ;
ADDINGTON, J ;
SCHISSEL, B .
SCHIZOPHRENIA RESEARCH, 1990, 3 (04) :247-251
[2]
[Anonymous], 1997, USERS GUIDE STRUCTUR
[3]
[Anonymous], 1915, Biometrika, DOI DOI 10.2307/2331838
[4]
[Anonymous], SCHIZOPHRENIA BULL
[5]
Appelbaum P., 2001, MACARTHUR COMPETENCE
[6]
A RATING-SCALE FOR DRUG-INDUCED AKATHISIA [J].
BARNES, TRE .
BRITISH JOURNAL OF PSYCHIATRY, 1989, 154 :672-676
[7]
TESTS OF SIGNIFICANCE IN FACTOR ANALYSIS [J].
Bartlett, M. S. .
BRITISH JOURNAL OF PSYCHOLOGY-STATISTICAL SECTION, 1950, 3 :77-85
[8]
Does negative symptom change relate to neurocognitive change in schizophrenia? Implications for targeted treatments [J].
Bell, MD ;
Mishara, AL .
SCHIZOPHRENIA RESEARCH, 2006, 81 (01) :17-27
[9]
The structure of negative symptoms within schizophrenia: Implications for assessment [J].
Blanchard, JJ ;
Cohen, AS .
SCHIZOPHRENIA BULLETIN, 2006, 32 (02) :238-245
[10]
Determinants of real-world functional performance in schizophrenia subjects: Correlations with cognition, functional capacity, and symptoms [J].
Bowie, CR ;
Reichenberg, A ;
Patterson, TL ;
Heaton, RK ;
Harvey, PD .
AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (03) :418-425